Wall Street Zen Downgrades Nanovibronix (NASDAQ:FEED) to Strong Sell

Nanovibronix (NASDAQ:FEED) was downgraded by stock analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a research note issued to investors on Monday.

Separately, Weiss Ratings initiated coverage on Nanovibronix in a report on Tuesday, January 27th. They set a “sell (e+)” rating for the company. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Nanovibronix Price Performance

Shares of FEED opened at $1.58 on Monday. The business’s 50 day moving average is $2.10. The company has a market cap of $1.72 million, a price-to-earnings ratio of -0.04 and a beta of 2.09. Nanovibronix has a 52 week low of $0.99 and a 52 week high of $71.50.

Nanovibronix (NASDAQ:FEED) last issued its quarterly earnings data on Wednesday, April 15th. The company reported ($20.00) EPS for the quarter. The company had revenue of $0.31 million for the quarter. Nanovibronix had a negative return on equity of 47.82% and a negative net margin of 712.30%.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.